Interestingly, TAC is an effective inhibitor of P-glycoprotein [49]; it has a potentially profound role in reversing multidrug resistance and is used in conjunction with anticancer therapy in ovarian cancer [50]. Here, ABCB1 is linked to ovarian carcinoma.